Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Jul 08, 2014 6:16pm
221 Views
Post# 22726709

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DO BLOOD LEVELS OF APOA-1 REALLY MATTER SO MUCH????

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DO BLOOD LEVELS OF APOA-1 REALLY MATTER SO MUCH????Hi GV.

I don't disagree with your first paragraph.

My perspective on this part of your post -  "This stock had many downs and if it wasn't for KD this stock would have been long gone. Therefore we need to look at the bright side and make the best of what we have and move on" is precisely the point I was trying to make about clarity and precision of communications not just to the scientific community and to the big players but also to the broader investment community.

I'll go back to the points I made when I first started posting;
  1. All companies operate within corporate cultures and paragdigms that can be both helpful and detremental.
  2. I sense the RVX culture is scientific and deal based.
  3. The science people will now be thrilled because they have bought themselves another year to test and invent (and, based on past transactions they probably are not worried about the future beyond this current financing because they look at the past and think there will be not problem getting funding in the future AND/OR they will be in high demand if RVX has to dial down the business) and inventing is what scientists like to do. So the science culture presents and networks at conferences. It motivates them to interact with equally bright and interesting people. Whether they actually get a product to market is of little consequence but a victory would be good. In science true discoveries are few and far between be we all want hope (including us small investors).
  4. The deal based culture is about keeping the business afloat....the only thing that counts is the deal. Don scores a deal and his team can work another year.
  5. Therefore, in my guess, the RVX culture does not and can not understand the value of building their brand because it is irrelevant to them.

Great companies, big, small and start ups recognize the power of communications to all stakeholders, shareholders, potential customers, etc. Great communications starts with brand positioning. When Nike was a tiny start up they highered a small ad agency from Seattle called Weiden and Kennedy. Neither had any money but they had ideas. Adidas and Puma dominated the sports markets but slowly Nike got it's message out and now dominate. What I'm saying is that RVX does not need alot of money to communicate successfully and with impact. It just takes expertise and creativity.

What you said as quoted up above is "we need to look on the bright side". I agree fully. RVX is on a swing up and there is no question of that in my mind but it needs to be leveraged not just to big pharma and biotech venture capital companies. It needs to reach out to the hundreds of thousands of average investors with some risk money to put at the top of their investment pyramid.

I read about a year ago that there are around 100 or so small cap biotech companies in Canada and thousands in the USA.
  • Therefore RVX needs to get itself noticed in this huge investment pool and be recognized.

I know what everyone is thinking and it's let's just be successful with ph2c and all problems are solved and BP will come begging. Probably true, but on the way there this stock could have a much higher value.

The other thing I've read is that RVX needs to rebuild it's reputation even before it can do Zenith IPOs. That is precisely what effective branding and positioning can do. We should not make the assumption that investors from the past that feel burned are the target market for the future. They have been scared and like me, it's their own fault. The target should be new investors.

I think you said that everything that needs to be communicated has been communicated (correct me if I'm wrong) and I agree, BUT it is in such a form that only venture capital biotech companies like Eastern and NGN understand it.

Some communications companies use the concept called the elevator speech which is basically "tell me what your company does in 7 words or less or on a trip up the elevator".

Anyway, what I'm trying to say is that we are on the upswing and the good news must get out. There is so much fantastically positive news for RVX that it should leveraged.

We are all looking for the diabetes results and Alheimers funding and we think that will move things ahead. But the impact could be much bigger with professional brand communications.

There should be a full out social media campagne that continuosly keeps the market excited UNLESS RVX does not really believe that ph2c will be successful.

Anyway, I know this will fall on deaf ears at RVX because they don't get it or feel communications is irrelevant.

A powerful campage should not impact Don's time and priorites. He should be focussed on Aug 13 and the preceeding announcments and the Zenith IPOs and getting the scientists focussed on ph2c.

It would be nice to see the market cap move way up just by telling people of their success.

Another long rant...I'll try not to repeat this theme again.
Cheers
Toinv




Bullboard Posts